This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2008-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Montréal, CA (2008)
- Montreal, CA (2011)
Company Filing History:
Years Active: 2008-2011
Title: Innovator René Coulombe: Pioneering Viral Polymerase Inhibitors
Introduction: René Coulombe, based in Montreal, Canada, stands out as an inventive mind in the field of pharmaceuticals. With a remarkable portfolio of two patents, his contributions are geared towards addressing significant health challenges such as hepatitis C. His innovations reflect a commitment to advancing medical science through novel therapeutic approaches.
Latest Patents: Coulombe's most recent patents focus on two critical aspects of hepatitis C treatment. The first patent entails "Viral polymerase inhibitors - Compounds of formula I," where certain compounds are identified as effective inhibitors of the hepatitis C virus NS5B polymerase. The second patent, "Hepatitis C Virus NS5B polymerase inhibitor binding pocket," reveals the structural conformations of the HCV NS5B polymerase when complexed with inhibitors. This significant research uncovers a binding pocket that presents a novel target for further chemical entities aimed at modulating or inhibiting the polymerase activity of HCV NS5B, enhancing the potential for innovative treatment strategies.
Career Highlights: René Coulombe has made substantial strides in his career at Boehringer Ingelheim International GmbH, a company renowned for its contributions to the pharmaceutical industry. His expertise and focused research have not only advanced his personal career but also contributed to the company's reputation as a leader in innovative healthcare solutions.
Collaborations: Throughout his journey, Coulombe has collaborated with other prominent researchers, such as Pierre Louis Beaulieu and Eric Jolicoeur, fostering an environment of shared knowledge and innovation. These collaborations have enabled the pooling of resources and ideas that enhance the quality and scope of their research.
Conclusion: René Coulombe's work exemplifies the impact of innovative thinking in the pharmaceutical industry. With his patents on viral polymerase inhibitors, he is paving the way for new treatments that could transform the landscape of hepatitis C management. As healthcare challenges continue to evolve, inventors like Coulombe will play a pivotal role in leading the charge towards effective solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile